The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade

Manuscript Number: 

17-9941

Author(s): 
Maíra Assunção Bicca, Erika N. Cline, William L. Klein, Kirsten L. Viola

Disclosures

Maíra Assunção Bicca

  • Nothing to Disclose

Erika N. Cline

  • Nothing to Disclose

William L. Klein

  • Equity:
    Founders shares in Acumen Pharmaceuticals, Inc.
    Patents/Royalties
    Patents pertaining to the composition and use of amyloid beta oligomers; patents pertaining to amyloid beta oligomer antibodies.
    Grants
    • Agency: 
      AbbVie
      Dates: 
      12/5/2015 - 12/4/2017

Kirsten L. Viola

  • Equity:
    Founding contributing member stock in Acumen Pharmaceuticals, Inc.
    Patents/Royalties
    Patents concerning the structure and uses of Amyloid beta oligomers. Patents concerning antibodies that target amyloid beta oligomers.